2GHL
Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743
Summary for 2GHL
Entry DOI | 10.2210/pdb2ghl/pdb |
Related | 1YW2 1YWR |
Descriptor | Mitogen-activated protein kinase 14, 3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA (3 entities in total) |
Functional Keywords | map kinase p38, p38, transferase |
Biological source | Mus musculus (house mouse) |
Cellular location | Cytoplasm : P47811 |
Total number of polymer chains | 1 |
Total formula weight | 40310.57 |
Authors | Walter, R.L.,Mekel, M.J.,Evdokimov, A.G.,Pokross, M.E.,Brugel, T.A. (deposition date: 2006-03-27, release date: 2006-04-11, Last modification date: 2024-02-14) |
Primary citation | Brugel, T.A.,Maier, J.A.,Clark, M.P.,Sabat, M.,Golebiowski, A.,Bookland, R.G.,Laufersweiler, M.J.,Laughlin, S.K.,Vanrens, J.C.,De, B.,Hsieh, L.C.,Mekel, M.J.,Janusz, M.J. Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1. Bioorg.Med.Chem.Lett., 16:3510-3513, 2006 Cited by PubMed Abstract: A new class of tumor necrosis factor alpha (TNF-alpha) synthesis inhibitors based on an N-2,4-pyrimidine-N-phenyl-N'-phenyl urea scaffold is described. Many of these compounds showed low-nanomolar activity against lipopolysaccharide stimulated TNF-alpha production. X-ray co-crystallization studies with mutated p38alpha showed that these trisubstituted ureas interact with the ATP-binding pocket in a pseudo-bicyclic conformation brought about by the presence of an intramolecular hydrogen bonding interaction. PubMed: 16632356DOI: 10.1016/j.bmcl.2006.03.095 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.099 Å) |
Structure validation
Download full validation report